Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

NOV Inc to Benefit from Easing Supply Chains - BofA

Published 09/30/2022, 03:13 PM
Updated 09/30/2022, 03:18 PM
© REUTERS NOV Inc (NOV) to Benefit from Easing Supply Chains - BofA

By Sam Boughedda

BofA analysts upgraded shares of NOV Inc (NYSE:NOV) to Buy from Neutral, maintaining a $19 per share price target.

They declared that 2023 could be the trickle-down year for the company.

"Since recent June highs, NOV is down 29%, which compares to capital equipment peer performance of: -24% CHX (ChampionX), flat FTI (TechnipFMC) and -29% WHD (Cactus)," wrote the analysts. "Shares have sold off amidst gusting macro headwinds, with 12-month Brent strip -25% over the same period."

They added that for NOV, its short-cycle businesses (Wellbore) are doing well, and longer-cycle businesses (CAPS, Rig Tech) are set to benefit from higher customer oil field services and capex and equipment tightness in NAM.

"Note NOV delivered strong EBITDA beats in 1H22 and mgmt. has guided to 2H Adj. EBITDA 45-55% above the 1H level. As such, consensus 2H22 EBITDA has risen 18% QTD to $387mm. We see NOV continuing to benefit from rising OFS capex, better pricing/fixed cost absorption, easing supply chains, and better mix," wrote the analysts.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.